Name | 2,4-dimethyl-1-(2,4,6-trimethyl-benzenesulfonyl)-1H-pyrrole |
---|---|
Synonyms |
HJC0350
HJC-0350 |
Description | HJC0350 is a potent and specific EPAC2 antagonist with an IC50 of 0.3 µM. |
---|---|
Related Catalog | |
Target |
IC50: 0.3 µM (EPAC2)[1] |
In Vitro | HJC0350 has an apparent IC50 value of 0.3 µM for competing with 8-NBD-cAMP binding of EPAC2, and is about 133-fold more potent than cAMP. HJC0350 is found not to inhibit EPAC1-mediated Rap1-GDP exchange activity at 25 µM in the presence of equal concentration of cAMP, indicating that it is EPAC2-specific antagonists. Pretreatment of HEK293/EPAC2-FL cells with 10 µM HJC0350 fully blocks the 007-AM induced decrease of FRET[1]. |
References |
Molecular Formula | C15H19NO2S |
---|---|
Molecular Weight | 277.38200 |
Exact Mass | 277.11400 |
PSA | 47.45000 |
LogP | 4.34790 |
Storage condition | -20℃ |
Hazard Codes | N |
---|---|
RIDADR | NONH for all modes of transport |